EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Comparative effectiveness of androgen receptor pathway inhibitor treatment intensification for metastatic hormone-sensitive prostate cancer in real-world patients

Chan Ho Lee iD, Soodong Kim iD, Ja Yoon Ku iD, Kyung Hwan Kim iD, Byeong Jin Kang iD, Hyeok Jun Goh iD, Won Ik Seo iD, Hong Koo Ha iD

Investigative and Clinical Urology · 2025

DOI: 10.4111/icu.20250313 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Investigative and Clinical Urology, 2025. Verfasst von Chan Ho Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea. Hauptthemen laut MEDLINE: Phenylthiohydantoin, Abiraterone Acetate, Thiohydantoins, Androgen Receptor Antagonists. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Busan Paik Hospital, Inje University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenylthiohydantoinAbiraterone AcetateThiohydantoinsAndrogen Receptor AntagonistsProstatic Neoplasms, Castration-ResistantProstatic NeoplasmsHumansMaleNitrilesBenzamidesRetrospective StudiesAgedMiddle AgedProstate-Specific AntigenAged, 80 and overTreatment OutcomeNeoplasm MetastasisProgression-Free Survival

Stichwörter der Autor:innen

Neoplasm metastasisProstate neoplasmsProstate specific antigenReceptors, androgen

Substanzen

NitrilesBenzamidesenzalutamideapalutamidePhenylthiohydantoinAbiraterone AcetateThiohydantoinsAndrogen Receptor AntagonistsProstate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • Department of Urology, Dong-A University College of Medicine, Busan, Korea.
  • Department of Urology, Dongnam Institute of Radiological & Medical Sciences Korea Cancer Center Hospital, Busan, Korea.
  • Department of Urology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
  • Biomedical Research Institute, Pusan National University Hospital, Busan, Korea. hongkooha@pusan.ac.kr.

ORCID-Profile: Chan Ho Lee, Soodong Kim, Ja Yoon Ku, Kyung Hwan Kim, Byeong Jin Kang, Hyeok Jun Goh, Won Ik Seo, Hong Koo Ha

Förderung

  • Busan Paik Hospital, Inje University

Zitieren

APA

Lee, C. H., Kim, S., Ku, J. Y., Kim, K. H., Kang, B. J., Goh, H. J., Seo, W. I., & Ha, H. K. (2025). Comparative effectiveness of androgen receptor pathway inhibitor treatment intensification for metastatic hormone-sensitive prostate cancer in real-world patients. Investigative and Clinical Urology. https://doi.org/10.4111/icu.20250313

Vancouver

Lee CH, Kim S, Ku JY, Kim KH, Kang BJ, Goh HJ, et al. Comparative effectiveness of androgen receptor pathway inhibitor treatment intensification for metastatic hormone-sensitive prostate cancer in real-world patients. Investigative and Clinical Urology. 2025. doi:10.4111/icu.20250313

BibTeX
@article{Lee2025,
  author = {Lee, Chan Ho and Kim, Soodong and Ku, Ja Yoon and Kim, Kyung Hwan and Kang, Byeong Jin and Goh, Hyeok Jun and Seo, Won Ik and Ha, Hong Koo},
  title = {Comparative effectiveness of androgen receptor pathway inhibitor treatment intensification for metastatic hormone-sensitive prostate cancer in real-world patients},
  journal = {Investigative and Clinical Urology},
  year = {2025},
  doi = {10.4111/icu.20250313}
}
Kostenlos starten →